Heart health check for cancer patients
Part of Heart & circulation, Injuries & trauma clinical trials.
This trial tests a new device that monitors heart health during cancer treatment. It uses a simple on-body sensor alongside your regular echocardiogram to see if it can detect heart changes early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for an echocardiogram (heart ultrasound) as part of your care
- You are willing to sign a consent form before any study activities
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a wearable heart monitor can help detect heart problems early in people receiving cancer treatment. It may help doctors manage heart health during therapy.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This trial is testing whether a lower radiation dose and a wearable heart monitor can reduce the risk of heart rhythm problems in people receiving chest radiation for cancer. It may help those at moderate-to-high risk of heart side effects from treatment.
This study tests a small chest sensor that tracks your heart activity while you're in the hospital. It may help doctors better manage heart failure and prevent future crises.
This feasibility study looks at how to support decision-making about preventing heart problems in adults after a cancer diagnosis. It may help by making it easier to assess cardiovascular risk and start appropriate heart-protection planning earlier.
This trial tests if a smartphone app or similar remote tools can help doctors catch early signs that heart failure is getting worse in people who have a defibrillator (ICD) or biventricular pacemaker (CRT) that sends data to the clinic. Participating helps researchers figure out if this type of check-in from home works better than standard care.
Hear when a new Cardiotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.